Quantitative Insights

Chicago, IL, United States  All United States companies → — Founded 2010
Imaging AI Specialist Specialty-Focused AI
Oncology Radiology
Oncology AI Radiology & Imaging AI
Acquired (previously received a Grant and was a University Spin-Out) — Undisclosed
Website Claim this company

Products

QuantX
Quantitative Insights
Oncology AI
QuantX by Quantitative Insights is an FDA-cleared AI-driven software platform for computer-aided diagnosis (CADx) of breast abnormalities using MRI, designed to enhance diagnostic accuracy and efficiency for radiologists.

See all 1 product →

About Quantitative Insights

Quantitative Insights was a healthcare AI company that developed a computer-aided diagnosis (CAD) system called QuantX, specifically designed to assist radiologists in the more accurate and efficient diagnosis of breast cancer. The company’s platform leveraged machine learning and advanced imaging analysis, integrating a deep database of historical cases to improve both the speed and accuracy of breast abnormality evaluations. Their technology aimed to provide an intuitive workstation for radiologists, enhancing patient management services through advanced research and imaging capabilities.

In July 2019, Quantitative Insights was acquired by Qlarity Imaging. Prior to its acquisition, the company had gained the industry’s first FDA clearance for a machine learning-driven cancer diagnosis system, as indicated by the provided PR Newswire link from 2017. Its focus remained on applying artificial intelligence and machine learning to critical areas within healthcare, particularly in oncology and diagnostic imaging.

What Physicians Need to Know

AI-Driven Cancer Diagnosis
Quantitative Insights specializes in developing machine learning-driven computer-aided diagnosis (CAD) platforms for cancer, initially focusing on breast abnormalities.
First FDA Clearance
Their flagship product, QuantXu2122, was the industry's first computer-aided diagnosis platform incorporating machine learning to receive FDA clearance for evaluating breast abnormalities.
Enhanced Diagnostic Performance
Clinical studies demonstrated that their technology significantly improves radiologists' diagnostic performance, leading to faster and more accurate diagnoses.
Physician Tip

For physicians, Quantitative Insights' technology, particularly QuantX, offers a significant advantage by augmenting diagnostic capabilities. It provides valuable additional information for multi-modality breast imaging decision support, increasing diagnostic confidence and improving reading times. The system has been shown to reduce missed breast cancers by 39% and achieve a 20% overall diagnostic improvement, enabling more personalized treatments and better patient outcomes. This AI tool is designed to work in conjunction with radiologists, not replace them, by providing advanced analytics and similarity assessments to a robust database of clinically documented pathologies.

Quantitative Insights' core product, QuantX, is a software platform designed to integrate with existing imaging workflows, providing advanced analytics and machine learning capabilities for decision support in breast imaging. It leverages quantitative imaging (radiomics) solutions.

Products by Quantitative Insights

1 product in the directory

QuantX
Quantitative Insights
Oncology AI
QuantX by Quantitative Insights is an FDA-cleared AI-driven software platform for computer-aided diagnosis (CADx) of breast abnormalities using MRI, designed to enhance diagnostic accuracy and efficiency for radiologists.

What the Web Says

Quantitative Insights, known for its QuantX product, received the industry's first FDA clearance for machine learning-driven cancer diagnosis, specifically for breast cancer. While this marks a significant technological advancement and positive industry recognition, public reviews from common platforms like G2, Glassdoor, Capterra, and Reddit are notably absent or extremely limited, making it difficult to assess widespread product satisfaction or employee experience.

Overall: Mixed

Strengths

  • First FDA clearance for machine learning-driven cancer diagnosis (QuantX)
  • Significant technological innovation in healthcare AI
  • Potential to improve accuracy and efficiency in cancer diagnosis
  • Positive recognition from regulatory bodies (FDA)
  • Addresses a critical need in medical imaging and diagnostics

Limitations

  • Lack of readily available product reviews on major platforms (G2, Capterra)
  • No discernible employee reviews on Glassdoor
  • Limited public discussion or reviews on Reddit
  • Difficulty in assessing user experience or company culture due to lack of data
  • Specific product features and user interface details are not widely reviewed

Based on reviews from: PRNewswire (for FDA clearance announcement), G2 (no relevant reviews found), Glassdoor (no relevant reviews found), Capterra (no relevant reviews found), Reddit (no significant discussions found)

Last updated: 2026-07-19

Videos

News, demos, and interviews about Quantitative Insights.

Loading videos...

Videos load interactively. If none appear, search YouTube for Quantitative Insights →

View all on YouTube

Press & Coverage

PR Newswire
Quantitative Insights Gains Industry's First FDA Clearance for Machine Learning Driven Cancer Diagnosis
Quantitative Insights received the first FDA clearance for a machine learning-driven cancer diagnosis system, QuantX, which assists radiologists in detecting breast cancer. The system uses AI to evaluate breast abnormalities from MRIs and medical data, aiming to improve diagnostic accuracy and reduce false negatives.
2017-07
Science and Enterprise
FDA Clears Algorithm-Assisted Cancer Diagnosis
The FDA cleared QuantX, a diagnostics system from Quantitative Insights that uses machine learning to help radiologists detect breast cancer, reducing false negatives by 39% in a clinical study. This system is a Class 2 device and was cleared through the de novo classification pathway.
2017-07
Institute for Translational Medicine (ITM)
FDA Clears ITM Investigator's Company's Computer-Aided Cancer Diagnosis Platform
Quantitative Insights, a company co-founded by ITM investigator Maryellen Giger, PhD, received FDA clearance for QuantX, its machine learning-driven platform for breast cancer diagnosis. The software evaluates MRIs and medical data to provide a 'QI score,' aiming for faster and more accurate detection.
2017-07
Fast Company
This AI breast cancer diagnostic tool is the first to get FDA clearance
QuantX, developed by Quantitative Insights and later acquired by Qlarity Imaging (Paragon Biosciences), was the first AI-powered breast cancer diagnosis system to receive FDA clearance. Clinical studies showed it improved radiologists' interpretation of MRIs, leading to a 39% reduction in missed breast cancers.
2019-07
UChicago Medicine
Artificial intelligence software for breast cancer diagnosis makes TIME's list of Best Inventions for 2019
QuantX, the FDA-cleared AI software for breast cancer diagnosis based on research by Maryellen Giger, PhD, at the University of Chicago, was named one of TIME's Best Inventions for 2019. It aims to reduce missed cancers and false positives by analyzing breast MRIs.
2019-12
Medical Product Outsourcing
FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched by Paragon Biosciences
Paragon Biosciences launched Qlarity Imaging, which acquired QuantX, the first FDA-cleared AI-powered breast cancer diagnosis system. QuantX, initially developed at the University of Chicago, demonstrated a 39% reduction in missed breast cancers in clinical studies.
2019-09
Polsky Center for Entrepreneurship and Innovation
Quantitative Insights Gaining Ground
Quantitative Insights, co-founded by Brian Luerssen and James Krocak, licensed intellectual property from the University of Chicago for its CADx platform. The company received an Innovation Fund award, was a finalist in the New Venture Challenge, and secured a $150,000 SBIR grant from the National Science Foundation.
2011-12
Tracxn
Quantitative Insights Funding Rounds, Valuation & Investors
Quantitative Insights has raised a total of $150K from one grant round on November 16, 2010, with the National Science Foundation as the sole institutional investor.
2010-11

Frequently Asked Questions

Quality Insights offers an advanced AI-driven framework, QAI, that provides high-value insights and supports decision-making for federal and state healthcare programs, providers, and participants. Their secure platform enables visual data engagement, offering QAI-powered dashboards for tracking quality metrics, an ROI Calculator, and tools for data collection and infrastructure assessments. They have also developed an AI model to improve emergency department triage by incorporating uncertainty into clinical predictions.
Quality Insights' QAI framework is designed to ensure data security and compliance, aiming to lower liability and improve the quality of care across healthcare networks. While specific HIPAA certifications for QAI are not detailed, the company emphasizes regulatory compliance and offers services like compliance reporting. In general, robust healthcare AI solutions adhere to HIPAA through measures like data encryption, access controls, and regular risk assessments.
The search results do not specify the exact pricing models for Quality Insights' QAI solutions. However, in the broader healthcare AI industry, decision-makers often prefer transparent and predictable hybrid pricing models, combining a base fee with variable components based on clinically meaningful units like per patient or per test. Integration, training, and ongoing support are generally considered integral components of the overall value and cost.
Quality Insights provides comprehensive support and training, including hands-on implementation assistance and extensive educational programs. These offerings encompass large-scale webinars, custom e-learning modules, and continuing education credits across various disciplines. They also offer customized consulting services focused on performance improvement and workflow optimization.
Yes, Quality Insights actively engages in partnerships, working with healthcare providers, public agencies, and community organizations at both national and local levels. They have established nearly 500 community-based partnerships and collaborate with government clients, healthcare providers, and program participants to improve health outcomes.
Quality Insights has a strong foundation, operating for over 50 years as a nonprofit dedicated to improving health outcomes. They have a proven track record of driving significant improvements, impacting millions of patients and Medicare beneficiaries, and achieving substantial cost savings through their initiatives. The organization is committed to continuous innovation and collaboration, indicating a stable and reliable presence in the healthcare landscape.

Comparisons

QuantX vs ContaCT
QuantX vs Viz Subdural+
QuantX vs Viz SDH
QuantX vs Viz CTP

Related Companies

Intelligent Voice AI (IVAI)
Scottsdale, Arizona

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext
London, United Kingdom

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex
San Francisco, CA, United States

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino
unknown

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI
New York, United States

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare
San Francisco, California, US

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.